Investigación / Grupos de investigación

Grupo  2

Fisiopatología e Historia Natural de las Enfermedades Hepáticas y Gastroenterológicas

Publicaciones (549)

  • Iavarone, M; Invernizzi, F; Ivanics, T; Mazza, S; Zavaglia, C; Sanduzzi-Zamparelli, M; Fraile-Lopez, M; Czauderna, C; Di Costanzo, G; Bhoori, S; Pinter, M; Manini, MA; Amaddeo, G; Yunquera, AF; Pinero, F; Rodriguez, MJB; Anders, M; Soteras, GA; Villadsen, GE; Yoon, PD; Cesarini, L; Diaz-Gonzalez, A; Gonzalez-Dieguez, ML; Tortora, R; Weinmann, A; Mazzaferro, V; Cristobal, MR; Crespo, G; Regnault, H; De Giorgio, M; Varela, M; Prince, R; Scudeller, L; Donato, MF; Worns, MA; Bruix, J; Sapisochin, G; Lampertico, P; Reig, M.

    Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study

    LIVER TRANSPLANTATION. 2021; 27(12): 1767-1778 Nº de citas: 27 [doi:10.1002/lt.26264]

  • da Costa-Seixas, JP; Lopez-Ceron, M; Arnau, A; Rosinol, O; Cuatrecasas, M; Herreros-de-Tejada, A; Ferrandez, A; Serra-Burriel, M; Nogales, O; de Castro, L; Lopez-Vicente, J; Vega, P; Alvarez-Gonzalez, MA; Gonzalez-Santiago, JM; Hernandez-Conde, M; Diez-Redondo, P; Rivero-Sanchez, L; Gimeno-Garcia, AZ; Burgos, A; Garcia-Alonso, FJ; Bustamante-Balen, M; Martinez-Bauer, E; Penas, B; Rodriguez-Alcalde, D; Pellise, M; Puig, I.

    Compound Endoscopic Morphological Features for Identifying Non-Pedunculated Lesions >= 20 mm with Intramucosal Neoplasia

    Cancers. 2021; 13(21): Nº de citas: 2 [doi:10.3390/cancers13215302]

  • Ventura-Cots, M; Simon-Talero, M; Poca, M; Ariza, X; Masnou, H; Sanchez, J; Llop, E; Canete, N; Martin-Llahi, M; Amador, A; Martinez, J; Clemente-Sanchez, A; Puente, A; Torrens, M; Alvarado-Tapias, E; Napoleone, L; Miquel-Planas, M; Ardevol, A; Rodrigo, MC; Calleja, JL; Sole, C; Soriano, G; Genesca, J.

    Effects of Albumin on Survival after a Hepatic Encephalopathy Episode: Randomized Double-Blind Trial and Meta-Analysis

    Journal of Clinical Medicine. 2021; 10(21): Nº de citas: 8 [doi:10.3390/jcm10214885]

  • Arab, JP; Diaz, LA; Baeza, N; Idalsoaga, F; Fuentes-Lopez, E; Arnold, J; Ramirez, CA; Morales-Arraez, D; Ventura-Cots, M; Alvarado-Tapias, E; Zhang, W; Clark, V; Simonetto, D; Ahn, JC; Buryska, S; Mehta, TI; Stefanescu, H; Horhat, A; Bumbu, A; Dunn, W; Attar, B; Agrawal, R; Haque, ZS; Majeed, M; Cabezas, J; Garcia-Carrera, I; Parker, R; Cuyas, B; Poca, M; Soriano, G; Sarin, SK; Maiwall, R; Jalal, PK; Abdulsada, S; Higuera-de la Tijera, MF; Kulkarni, AV; Rao, PN; Salazar, PG; Skladany, L; Bystrianska, N; Prado, V; Clemente-Sanchez, A; Rincon, D; Haider, T; Chacko, KR; Cairo, F; Coelho, MD; Romero, GA; Pollarsky, FD; Restrepo, JC; Castro-Sanchez, S; Toro, LG; Yaquich, P; Mendizabal, M; Garrido, ML; Narvaez, A; Bessone, F; Marcelo, JS; Piombino, D; Dirchwolf, M; Arancibia, JP; Altamirano, J; Kim, W; Araujo, RC; Rojo, AD; Vargas, V; Rautou, PE; Issoufaly, T; Zamarripa, F; Torre, A; Lucey, MR; Mathurin, P; Louvet, A; Garcia-Tsao, G; Gonzalez, JA; Verna, E; Brown, RS; Roblero, JP; Abraldes, JG; Arrese, M; Shah, VH; Kamath, PS; Singal, AK; Bataller, R.

    Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study

    JOURNAL OF HEPATOLOGY. 2021; 75(5): 1026-1033 Nº de citas: 90 [doi:10.1016/j.jhep.2021.06.019]

  • Caballero-Marcos, A; Romero-Cristobal, M; Puerto, M; Fernandez-Yunquera, A; Dieguez, L; Navarrete, C; Clemente, A; Diaz-Fontenla, F; Catalan, P; Rincon, D; Lopez-Baena, JA; Canizares, RB; Salcedo, M.

    HCV eradication in recurrent hepatitis C after liver transplantation normalizes enhanced endothelial activation

    TRANSPLANT INTERNATIONAL. 2021; 34(11): 2214-2225 Nº de citas: 3 [doi:10.1111/tri.14000]

  • Ahumada, A; Rayon, L; Uson, C; Banares, R; Lopez, SA.

    Hepatocellular carcinoma risk after viral response in hepatitis C virus-advanced fibrosis: Who to screen and for how long?

    WORLD JOURNAL OF GASTROENTEROLOGY. 2021; 27(40): 6737-6749 Nº de citas: 11 [doi:10.3748/wjg.v27.i40.6737]

  • García MJ; Rivero M; Miranda-Bautista J; Bastón-Rey I; Mesonero F; Leo-Carnerero E; Casas-Deza D; Cagigas Fernández C; Martin-Cardona A; El Hajra I; Hernández-Aretxabaleta N; Pérez-Martínez I; Fuentes-Valenzuela E; Jiménez N; Rubín de Célix C; Gutiérrez A; Suárez Ferrer C; Huguet JM; Fernández-Clotet A; González-Vivó M; Del Val B; Castro-Poceiro J; Melcarne L; Dueñas C; Izquierdo M; Monfort D; Bouhmidi A; Ramírez De la Piscina P; Romero E; Molina G; Zorrilla J; Calvino-Suárez C; Sánchez E; Nuñez A; Sierra O; Castro B; Zabana Y; González-Partida I; De la Maza S; Castaño A; Nájera-Muñoz R; Sánchez-Guillén L; Riat Castro M; Rueda JL; Benítez JM; Delgado-Guillena P; Tardillo C; Peña E; Frago-Larramona S; Rodríguez-Grau MC; Plaza R; Pérez-Galindo P; Martínez-Cadilla J; Menchén L; Barreiro-De Acosta M; Sánchez-Aldehuelo R; De la Cruz MD; Lamuela LJ; Marín I; Nieto-García L; López-San Román A; Herrera JM; Chaparro M; Gisbert JP.

    Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu

    Journal of Clinical Medicine. 2021; 10(19): Nº de citas: 7 [doi:10.3390/jcm10194402]

  • Estevez-Vazquez, O; Benede-Ubieto, R; Guo, FF; Gomez-Santos, B; Aspichueta, P; Reissing, J; Bruns, T; Sanz-Garcia, C; Sydor, S; Bechmann, LP; Maranillo, E; Sanudo, JR; Vazquez, MT; Lamas-Paz, A; Moran, L; Mazariegos, MS; Ciudin, A; Pericas, JM; Peligros, MI; Vaquero, J; Martinez-Naves, E; Liedtke, C; Regueiro, JR; Trautwein, C; Banares, R; Cubero, FJ; Nevzorova, YA.

    Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD)

    Biomedicines. 2021; 9(10): Nº de citas: 1 [doi:10.3390/biomedicines9101289]

  • Miranda-Bautista, J; Rodriguez-Feo, JA; Puerto, M; Lopez-Cauce, B; Lara, JM; Gonzalez-Novo, R; Martin-Hernandez, D; Ferreiro-Iglesias, R; Banares, R; Menchen, L.

    Liver X Receptor Exerts Anti-Inflammatory Effects in Colonic Epithelial Cells via ABCAI and Its Expression Is Decreased in Human and Experimental Inflammatory Bowel Disease

    INFLAMMATORY BOWEL DISEASES. 2021; 27(10): 1661-1673 Nº de citas: 5 [doi:10.1093/ibd/izab034]

  • Belli, LS; Duvoux, C; Cortesi, PA; Facchetti, R; Iacob, S; Perricone, G; Radenne, S; Conti, S; Patrono, D; Berlakovich, G; Hann, A; Pasulo, L; Castells, L; Faitot, F; Detry, O; Invernizzi, F; Magini, G; De Simone, P; Kounis, I; Morelli, MC; Fontenla, FD; Ericzon, BG; Loinaz, C; Johnston, C; Gheorghe, L; Lesurtel, M; Romagnoli, R; Kollmann, D; Perera, MTPR; Fagiuoli, S; Mirza, D; Coilly, A; Toso, C; Zieniewicz, K; Elkrief, L; Karam, V; Adam, R; den Hoed, C; Merli, M; Puoti, M; De Carlis, L; Oniscu, GC; Piano, S; Angeli, P; Fondevila, C; Polak, WG; Ctr Contributing ELITA-ELTR.

    COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort study

    GUT. 2021; 70(10): 1914-1924 Nº de citas: 32 [doi:10.1136/gutjnl-2021-324879]

  • Coll, E; Fernandez-Ruiz, M; Padilla, M; Moreso, F; Hernandez-Vicente, A; Yanez, I; Molina, M; Vazquez-Sanchez, T; Crespo, M; Facundo, C; Rodriguez-Ferrero, ML; Fuentes, MCR; Loinaz, C; Bernal, G; Melilli, E; Bravo, C; Diekmann, F; Llado, L; Garcia-Alvarez, TM; Salcedo, M; Beneyto, I; Castells, L; Alonso, R; Rodriguez-Benot, A; Diaz-Corte, C; Graus, J; Ortiz-Bautista, C; Garcia-Cosio, MD; Hinojal, R; Pena, L; Dominguez-Gil, B.

    COVID-19 in Solid Organ Transplant Recipients in Spain Throughout 2020: Catching the Wave?

    TRANSPLANTATION. 2021; 105(10): 2146-2155 Nº de citas: 27 [doi:10.1097/TP.0000000000003873]

  • Sleutjes, JAM; van Lennep, JER; Boersma, E; Menchen, LA; Laudes, M; Farkas, K; Molnar, T; Kennedy, NA; Pierik, MJ; van der Woude, CJ; de Vries, AC.

    Systematic review with meta-analysis: effect of inflammatory bowel disease therapy on lipid levels

    ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2021; 54(8): 999-1012 Nº de citas: 9 [doi:10.1111/apt.16580]

  • Kudo, M; Matilla, A; Santoro, A; Melero, I; Gracian, AC; Acosta-Rivera, M; Choo, SP; El-Khoueiry, AB; Kuromatsu, R; El-Rayes, B; Numata, K; Itoh, Y; Di Costanzo, F; Crysler, O; Reig, M; Shen, Y; Neely, J; Tschaika, M; Wisniewski, T; Sangro, B.

    CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis

    JOURNAL OF HEPATOLOGY. 2021; 75(3): 600-609 Nº de citas: 164 [doi:10.1016/j.jhep.2021.04.047]

  • Pérez-Lago L; Martínez-Lozano H; Pajares Díaz JA; Díaz Gómez A; Machado M; Sola-Campoy PJ; Herranz M; Buenestado-Serrano S; Valerio M; Olmedo M; Andrés Zayas C; Comas I; González Candelas F; Bañares R; Catalán P; Muñoz P; García de Viedma D.

    Proper Assignation of Reactivation in a COVID-19 Recurrence Initially Interpreted as a Reinfection.

    JOURNAL OF INFECTIOUS DISEASES. 2021; 224(5): 788-792 Nº de citas: 4 [doi:10.1093/infdis/jiab302]

  • Marin-Jimenez, I; Carrascosa, JM; Guigini, MA; Monte-Boquet, E.

    Knowledge, perceptions, attitude, barriers and facilitators of biosimilars use across specialty physicians and hospital pharmacists: A national survey

    FARMACIA HOSPITALARIA. 2021; 45(5): 240-246 Nº de citas: 9 [doi:10.7399/fh.11662]

  • Gomez-Cid, L; Lopez-Donaire, ML; Velasco, D; Marin, V; Gonzalez, MI; Salinas, B; Cusso, L; Garcia, A; Bravo, SB; Fernandez-Santos, ME; Elvira, C; Sierra, J; Arroba, E; Bañares R; Grigorian-Shamagian, L; Fernandez-Aviles, F.

    Cardiac Extracellular Matrix Hydrogel Enriched with Polyethylene Glycol Presents Improved Gelation Time and Increased On-Target Site Retention of Extracellular Vesicles

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021; 22(17): Nº de citas: 12 [doi:10.3390/ijms22179226]

  • Villanueva, C; Albillos, A; Genesca, J; Garcia-Pagan, JC; Brujats, A; Calleja, JL; Aracil, C; Banares, R; Morillas, RM; Poca, M; Penas, B; Augustin, S; Abraldes, JG; Alvarado, E; Torres, F; Bosch, J; PreDesCI Study Investigators.

    Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis

    JOURNAL OF HEPATOLOGY. 2021; 75(3): 589-599 Nº de citas: 44 [doi:10.1016/j.jhep.2021.04.022]

  • Ampuero, J; Aller, R; Gallego-Duran, R; Crespo, J; Abad, J; Gonzalez-Rodriguez, A; Gomez-Camarero, J; Caballeria, J; Lo Iacono, O; Ibanez, L; Garcia-Samaniego, J; Martin-Mateos, R; Frances, R; Fernandez-Rodriguez, C; Diago, M; Soriano, G; Andrade, RJ; Latorre, R; Jorquera, F; Morillas, RM; Escudero, D; Estevez, P; Hernandez-Guerra, M; Augustin, S; Pareja-Megia, MJ; Banales, JM; Aspichueta, P; Benlloch, S; Rosales, JM; Salmeron, J; Turnes, J; Romero-Gomez, M; HEPAmet Registry.

    Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects

    LIVER INTERNATIONAL. 2021; 41(9): 2076-2086 Nº de citas: 12 [doi:10.1111/liv.14898]